Director of Illicit Drugs, Public Health and Policy Unit at the Centre for Addictions Research
Pro to the question "Should Marijuana Be a Medical Option?"
"While further research is required on the biological and clinical aspects of the benefits of cannabis use for HCV [hepatitis C] treatment, and the effectiveness of cannabis use for HCV treatment needs to be explored in larger study populations, we advocate that in the interim existing barriers to cannabis use are removed for drug users undergoing HCV treatment until the conclusive empirical basis for evidence-based guidance is available."
European Journal of Gastroenterology & Hepatology, Oct. 2006
Experts PhD's and JD's (lawyers) with significant post-doctoral involvement in medical marijuana issues; judges who have presided over medical marijuana cases. [Note: Experts definition varies by site.]
Involvement and Affiliations:
Director, Illicit Drugs, Public Health and Policy Unit, Centre for Addictions Research, University of Victoria, 2006-present
Former Research Scientist and Section Co-Head, Public Health and Regulatory Policy at the Centre for Addiction and Mental Health (CAMH), Toronto
Former Associate Professor, Public Health Sciences and Criminology, University of Toronto
Recipient, New Investigator Research Career Award, Canadian Institutes of Health Research, 2001-2006
Recipient, Anthony Miller Research Award for Excellence in Research in Public Health; Department of Public Health Sciences, University of Toronto, 2003
Recipient, IVO Award (biennial international award for research excellence in substance use/addiction studies); Addiction Research Institute (IVO), Rotterdam, Netherlands, 2002
Cowritten with with L. Popova, J. Rehm, and A. Ivsins, "Drug Use-Related Overdose Mortality in British Columbia and Ontario, 1992-2002," Canadian Journal of Public Health
Cowritten with J. Rehm, G. Kim, and M. Kirst, "Eyes Wide Shut? A Conceptual and Empirical Critique of Methadone Maintenance Treatment (MMT)," European Addiction Research, 2005
Cowritten with J. Rehm, E. Haydon, M. Krajden, and J. Reimer, "Injection Drug Use and the Hepatitis C Virus: Opportunities ad Needs For a Targeted Treatment Approach - The Case Study of Canada," Journal of Urban Health, 2004